PGHH2024-01-012024-03-31 PGHH2024-01-012024-03-31 PGHH2024-01-012024-03-31in-bse-fin:OneOperatingExpenses01Member PGHH2024-01-012024-03-31in-bse-fin:OneOperatingExpenses02Member PGHH2024-01-012024-03-31in-bse-fin:FourOperatingExpenses01Member PGHH2024-01-012024-03-31in-bse-fin:FourOperatingExpenses02Member PGHH2024-03-31 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 500459 PGHH NOTLISTED Procter & Gamble Hygiene and Health Care Limited Equity 2023-07-01 2024-06-30 2024-04-30 2024-03-27 INR Lakhs Third quarter 12:20:00 13:07:00 2024-04-30 2024-04-30 Not applicable Single segment Hygiene and Healthcare 2024-01-01 2024-03-31 Unaudited Standalone 10021700000.00 135900000.00 10157600000.00 1640000000.00 1808600000.00 -71000000.00 600900000.00 224200000.00 145400000.00 3470100000.00 7818200000.00 2339400000.00 0.00 2339400000.00 877700000.00 -82000000.00 795700000.00 0.00 1543700000.00 0.00 0.00 0.00 0.00 1543700000.00 32100000.00 1575800000.00 0.00 0.00 324600000.00 10 47.56 47.56 0.00 0.00 47.56 47.56 1.The above results have been reviewed by the Audit committee and approved by the Board of Directors of the Company at their respective meetings held on April 30,2024 and have been subjected to limited review by the statutory auditors of the Company. 2.The Company has arrived at an advanced pricing agreement with the concerned tax authorities, determining appropriate transfer pricing methodology for certain identified transactions with the Company's affiliates for the years FY. 2010-11 to F.Y 2018-19. As a consequence of this agreement, an addiitonal tax liability amounting to Rs. 1660 lakhs and interest of Rs. 1930 lakhs has been accounted under prior period tax adjustments and finance costs respectively. Further, there will be reduction in contingent liability of approximately Rs. 8699 lakh, subject to withdrawal of relevant tax litigations by the respective parties. 3. During the period ended March 2023 and year ended June 2023, the Company had reversed tax provisions amounting to Rs. 5844 lakhs in respect of past income tax litigations pertaining to certain years, based on favourable ruling by the Income Tax Appellate Tribunal in a similar case of the Company pertaining to an earlier year. 4. The Company has identified health and hygiene products as its single primary reportable segment in accordance with the requirements if Ind AS 108- operating segments, accordingly no separate segment information is provided. For 3 months ended March 31,2024, Current tax includes prior year adjustments of Rs. 1810 lakh For 9 months ended March 31,2024, Current tax includes prior year adjustments of Rs. 1576 lakh For 9 months ended March 31,2024, deferred tax includes prior year adjustments of Rs. 467 lakh Single segment 2023-07-01 2024-03-31 Unaudited Standalone 32739500000.00 449400000.00 33188900000.00 5950900000.00 6225800000.00 161700000.00 1785100000.00 268600000.00 431000000.00 10096600000.00 24919700000.00 8269200000.00 0.00 8269200000.00 2424800000.00 -95200000.00 2329600000.00 0.00 5939600000.00 0.00 0.00 0.00 0.00 5939600000.00 69100000.00 6008700000.00 0.00 0.00 324600000.00 10 182.98 182.98 0.00 0.00 182.98 182.98 Advertising & Sales Promotion 1340900000.00 Other Expenses 2129200000.00 Advertising & Sales Promotion 4142600000.00 Other Expenses 5954000000.00 42900000.00 92400000.00 10800000.00 23300000.00 0.00 0.00